Intrinsiqs

Is Acadia Pharmaceuticals Inc. overvalued?

Acadia Pharmaceuticals Inc. (ACAD) looks undervalued — trading about 25% below its fair value.

Undervalued
Current price $18.75 Fair value $23.49
Price
$18.75
Fair value
$23.49
Current P/E
9.2
Normal P/E
11.5
Market cap
$3.24B
Dividend yield
0.0%
Return on equity
28.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ACAD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.